XENETIC BIOSCIENCES, INC. Interest Expense
XENETIC BIOSCIENCES, INC. (XBIO) reported Interest Expense of $1.82 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-30.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2018-03-30
- XENETIC BIOSCIENCES, INC. interest expense for the quarter ending 2017-12-31 was $349.00, a 99.12% decline year-over-year.
- XENETIC BIOSCIENCES, INC. interest expense for the quarter ending 2017-09-30 was $425.00, a 99.88% decline year-over-year.
- XENETIC BIOSCIENCES, INC. interest expense for the quarter ending 2017-06-30 was $456.00, a 99.56% decline year-over-year.
- XENETIC BIOSCIENCES, INC. interest expense for the quarter ending 2017-03-31 was $588.00, a 99.76% decline year-over-year.
- XENETIC BIOSCIENCES, INC. interest expense for fiscal 2017 was $1.82K, a 99.75% decline from fiscal 2016.
- XENETIC BIOSCIENCES, INC. interest expense for fiscal 2016 was $729.57K, a 173.25% increase from fiscal 2015.
- XENETIC BIOSCIENCES, INC. interest expense for fiscal 2015 was $267.00K, a 5573.59% increase from fiscal 2014.
- XENETIC BIOSCIENCES, INC. interest expense for fiscal 2014 was $4.71K, a 644.62% increase from fiscal 2013.
| Period end | Interest Expense 1 month | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 7 month | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 10 month | Interest Expense 12 month | Interest Expense 19 month | Interest Expense 22 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $349.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $774.00 derived: sum of 2 quarters · filed 2018-03-30 | $1.23K derived: sum of 3 quarters · filed 2018-03-30 | $1.82K 10-K · filed 2018-03-30 | ||||||
| 2017-09-30 | $425.00 10-Q · filed 2017-11-14 | $881.00 derived: sum of 2 quarters · filed 2017-11-14 | $1.47K 10-Q · filed 2017-11-14 | $40.92K derived: sum of 4 quarters · filed 2018-03-30 | ||||||
| 2017-06-30 | $456.00 10-Q · filed 2017-08-14 | $1.04K 10-Q · filed 2017-08-14 | $40.50K derived: sum of 3 quarters · filed 2018-03-30 | $382.15K derived: sum of 4 quarters · filed 2018-03-30 | ||||||
| 2017-03-31 | $588.00 10-Q · filed 2017-05-15 | $40.04K derived: sum of 2 quarters · filed 2018-03-30 | $381.69K derived: sum of 3 quarters · filed 2018-03-30 | $484.78K derived: sum of 4 quarters · filed 2018-03-30 | ||||||
| 2016-12-31 | $39.45K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $381.10K derived: sum of 2 quarters · filed 2018-03-30 | $484.19K derived: sum of 3 quarters · filed 2018-03-30 | $729.57K 10-K · filed 2018-03-30 | ||||||
| 2016-09-30 | $341.65K 10-Q · filed 2017-11-14 | $444.73K derived: sum of 2 quarters · filed 2017-11-14 | $690.12K 10-Q · filed 2017-11-14 | $826.71K derived: sum of 4 quarters · filed 2017-11-14 | ||||||
| 2016-06-30 | $103.09K 10-Q · filed 2017-08-14 | $348.47K 10-Q · filed 2017-08-14 | $485.06K derived: sum of 3 quarters · filed 2017-08-14 | $612.96K derived: sum of 4 quarters · filed 2017-08-14 | ||||||
| 2016-03-31 | $245.38K 10-Q · filed 2017-05-15 | $381.98K derived: sum of 2 quarters · filed 2017-05-15 | $509.87K derived: sum of 3 quarters · filed 2017-05-15 | $511.26K derived: sum of 4 quarters · filed 2017-05-15 | ||||||
| 2015-12-31 | $136.59K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $264.49K derived: sum of 2 quarters · filed 2017-03-31 | $265.87K derived: sum of 3 quarters · filed 2017-03-31 | $267.00K 10-K · filed 2017-03-31 | ||||||
| 2015-09-30 | $127.90K 10-Q · filed 2016-11-14 | $129.28K derived: sum of 2 quarters · filed 2016-11-14 | $130.41K 10-Q · filed 2016-11-14 | $75.94K 10-Q · filed 2015-11-16 | $135.11K derived: sum of 4 quarters · filed 2016-11-14 | |||||
| 2015-06-30 | $1.39K 10-Q · filed 2016-08-15 | $2.51K 10-Q · filed 2016-08-15 | $7.22K derived: sum of 3 quarters · filed 2016-08-15 | $8.41K derived: sum of 4 quarters · filed 2016-08-15 | ||||||
| 2015-03-31 | $1.13K 10-Q · filed 2016-05-16 | $5.83K derived: sum of 2 quarters · filed 2016-05-16 | $7.03K derived: sum of 3 quarters · filed 2016-05-16 | $8.52K derived: sum of 4 quarters · filed 2016-05-16 | ||||||
| 2014-12-31 | $4.71K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $5.90K derived: sum of 2 quarters · filed 2016-03-30 | $7.39K derived: sum of 3 quarters · filed 2016-03-30 | $4.71K 10-K · filed 2016-03-30 | ||||||
| 2014-09-30 | $1.20K 10-Q · filed 2014-11-14 | $2.69K derived: sum of 2 quarters · filed 2015-08-19 | $0.00 10-Q · filed 2015-11-16 | $3.57K 10-Q · filed 2014-11-14 | $3.57K derived: sum of 4 quarters · filed 2015-08-19 | |||||
| 2014-06-30 | $1.49K 10-Q · filed 2015-08-19 | $2.37K 10-Q · filed 2015-08-19 | $2.37K derived: sum of 3 quarters · filed 2015-08-19 | |||||||
| 2014-03-31 | $884.00 10-Q · filed 2015-05-20 | $884.00 derived: sum of 2 quarters · filed 2015-07-20 | ||||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-20 | $632.00 10-K · filed 2015-07-20 | ||||||||
| 2013-11-30 | -$5.70K 10-Q · filed 2014-01-10 | |||||||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $632.00 10-Q · filed 2014-11-14 | ||||||||
| 2013-08-31 | -$3.23K derived: 10-K 12 month − 10-Q 9 month · filed 2013-11-27 | -$12.95K 10-K · filed 2013-11-27 | ||||||||
| 2013-06-30 | $632.00 10-Q · filed 2014-08-14 | $632.00 10-Q · filed 2014-08-14 | ||||||||
| 2013-05-31 | -$3.36K 10-Q · filed 2013-07-17 | -$6.52K derived: sum of 2 quarters · filed 2013-07-17 | -$9.71K 10-Q · filed 2013-07-17 | -$12.95K derived: sum of 4 quarters · filed 2014-01-10 | -$23.59K 10-Q · filed 2013-07-17 | |||||
| 2013-02-28 | -$3.16K 10-Q · filed 2013-04-22 | -$6.36K 10-Q · filed 2013-04-22 | -$9.59K derived: sum of 3 quarters · filed 2014-01-10 | -$12.82K derived: sum of 4 quarters · filed 2014-01-10 | -$20.23K 10-Q · filed 2013-04-22 | |||||
| 2012-12-31 | $51.74K 10-K · filed 2015-07-20 | |||||||||
| 2012-11-30 | -$3.20K 10-Q · filed 2014-01-10 | -$6.43K derived: sum of 2 quarters · filed 2014-01-10 | -$9.66K derived: sum of 3 quarters · filed 2014-01-10 | -$12.86K derived: sum of 4 quarters · filed 2014-01-10 | ||||||
| 2012-08-31 | -$3.23K derived: 10-K 12 month − 10-Q 9 month · filed 2013-11-27 | -$6.46K derived: sum of 2 quarters · filed 2013-11-27 | -$9.66K derived: sum of 3 quarters · filed 2013-11-27 | -$13.01K 10-K · filed 2013-11-27 | ||||||
| 2012-05-31 | -$3.23K 10-Q · filed 2013-07-17 | -$6.43K derived: sum of 2 quarters · filed 2013-07-17 | -$9.78K 10-Q · filed 2013-07-17 | -$10.64K 10-Q · filed 2012-07-16 | ||||||
| 2012-02-29 | -$3.20K 10-Q · filed 2013-04-22 | -$6.55K 10-Q · filed 2013-04-22 | -$7.41K 10-Q · filed 2012-04-24 | |||||||
| 2011-11-30 | -$3.35K 10-Q · filed 2013-01-22 | |||||||||
| 2011-08-31 | -$861.00 10-K · filed 2012-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |